Park Ha Biological Technology
BYAH
3 hedge funds and large institutions have $71 invested in Park Ha Biological Technology in 2026 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
50% more funds holding
Funds holding: 2 → 3 (+1)
2.55% less ownership
Funds ownership: 2.55% → 0% (-2.5%)
100% less capital inflows, than outflows
Capital inflows: $90 | Capital outflows: $39.1K
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$87 |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Virtu Financial
New York
|
-$29K |
| 2 |
Morgan Stanley
New York
|
-$10.1K |
| 3 |
Caitong International Asset Management
Hong Kong
|
-$3 |
BYAH Hedge Fund Activity: Q3 2026 in Review
3 of the 8,221 institutional investors tracked by Wall St. Rank reported a position in Park Ha Biological Technology (BYAH) for Q3 2026, worth a combined $71 — down 100% from $54.3K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BYAH positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $87. The largest seller was Virtu Financial, exiting entirely with an estimated $29K sold.
- 3 institutional investors held Park Ha Biological Technology (BYAH) as of Q3 2026, up from 2 in Q2 2026.
- Funds reported $71 of Park Ha Biological Technology stock for Q3 2026, down 100% quarter-over-quarter.
- 2 funds opened new Park Ha Biological Technology positions in Q3 2026 and 1 closed out, a net change of +1 holder.
- The largest Park Ha Biological Technology buyer in Q3 2026 was JP Morgan Chase, an estimated $87 added.
- The largest Park Ha Biological Technology seller in Q3 2026 was Virtu Financial, an estimated $29K sold.
Based on aggregated 13F filings for Q3 2026.